Crystal structure of a complex between anthrax toxin and its host cell receptor

Nature
Eugenio SantelliR Liddington

Abstract

Anthrax toxin consists of the proteins protective antigen (PA), lethal factor (LF) and oedema factor (EF). The first step of toxin entry into host cells is the recognition by PA of a receptor on the surface of the target cell. Subsequent cleavage of receptor-bound PA enables EF and LF to bind and form a heptameric PA63 pre-pore, which triggers endocytosis. Upon acidification of the endosome, PA63 forms a pore that inserts into the membrane and translocates EF and LF into the cytosol. Two closely related host cell receptors, TEM8 and CMG2, have been identified. Both bind to PA with high affinity and are capable of mediating toxicity. Here, we report the crystal structure of the PA-CMG2 complex at 2.5 A resolution. The structure reveals an extensive receptor-pathogen interaction surface mimicking the non-pathogenic recognition of the extracellular matrix by integrins. The binding surface is closely conserved in the two receptors and across species, but is quite different in the integrin domains, explaining the specificity of the interaction. CMG2 engages two domains of PA, and modelling of the receptor-bound PA63 heptamer suggests that the receptor acts as a pH-sensitive brace to ensure accurate and timely membrane insertion. The...Continue Reading

References

Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Feb 27, 1997·Nature·C PetosaR C Liddington
Apr 2, 1998·Biochemistry·E L BensonR J Collier
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Aug 11, 1999·Biochemistry·C J MillerR J Collier
Nov 9, 2001·Nature·K A BradleyJ A Young
Jan 30, 2002·Biochemistry·Shilla NassiAlan Finkelstein
Jan 29, 2003·The Journal of Cell Biology·Laurence AbramiF Gisou van der Goot
Apr 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Heather M ScobieJohn A T Young
Jul 26, 2003·Expert Opinion on Biological Therapy·Shihui LiuStephen H Leppla
Sep 26, 2003·The Journal of Biological Chemistry·Kenneth A BradleyJohn A T Young
Oct 14, 2003·Current Pharmaceutical Design·Arthur E FrankelGeorge F Vande Woude
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael MourezRodney K Tweten
Dec 20, 2003·Current Opinion in Oncology·Akash Nanda, Brad St Croix
Dec 31, 2003·Methods in Enzymology·Richard J MorrisVictor S Lamzin
Feb 12, 2004·Cancer Research·Akash NandaBrad St Croix
Mar 24, 2004·Current Opinion in Microbiology·Mahtab Moayeri, Stephen H Leppla
Mar 27, 2004·The Journal of Biological Chemistry·Darran J WigelsworthR John Collier
Apr 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·D Borden LacyR John Collier
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

Aug 5, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Qimeng QuanXiaoyuan Chen
Jul 24, 2008·The Protein Journal·Momchilo VuyisichGoutam Gupta
Mar 31, 2005·Journal of Structural Biology·Thanh X DangElizabeth M Wilson-Kubalek
Sep 8, 2012·Journal of Medicinal Chemistry·Alexander N WeinMichael Peredelchuk
Aug 20, 2004·Nature·James G Bann, Scott J Hultgren
Apr 2, 2005·Nature Reviews. Drug Discovery·James C BurnettSina Bavari
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mazdak RadjainiaAlok K Mitra
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mikhail MartchenkoStanley N Cohen
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Panagiotis PapatheodorouKlaus Aktories
Jul 21, 2009·The Journal of Biological Chemistry·Nareen AbboudArturo Casadevall
Aug 8, 2012·The Journal of Biological Chemistry·Adva MechalyOhad Mazor
Jan 6, 2011·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Chenguang CaiZhiyong Lou
Dec 22, 2006·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K A RmaliW G Jiang
Dec 17, 2008·Antimicrobial Agents and Chemotherapy·Shilpi SharmaJohn A T Young
Aug 26, 2009·Infection and Immunity·Cassandra D Kelly-Cirino, Nicholas J Mantis
Oct 22, 2008·Infection and Immunity·Mandy Y GoJeremy Mogridge
May 16, 2006·Journal of Virology·Michael J McConnellMichael J Imperiale
Mar 6, 2007·Annual Review of Biochemistry·John A T Young, R John Collier
Oct 24, 2006·PLoS Pathogens·Heather M ScobieJohn A T Young
Oct 10, 2007·PLoS Pathogens·Darly J ManayaniAnette Schneemann
Dec 17, 2011·PLoS Pathogens·Rosemarie M PilpaJohn A T Young
Jun 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Roman A Melnyk, R John Collier
Sep 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·G Jonah A RaineyJohn A T Young
Aug 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Saleem BashaRavi S Kane
Apr 30, 2014·Annual Review of Biophysics·Woon Ju SongF Akif Tezcan
Nov 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sen ZhangR John Collier
Mar 4, 2009·Expert Review of Anti-infective Therapy·Jean-Nicolas TournierBradley G Stiles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
D Borden LacyR John Collier
Proceedings of the National Academy of Sciences of the United States of America
G Jonah A RaineyJohn A T Young
Proceedings of the National Academy of Sciences of the United States of America
D Borden LacyR John Collier
© 2022 Meta ULC. All rights reserved